Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'20
No of Months
12
12
12
12
12
Operating Income
1,200.00
1,016.00
853.00
712.00
512.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
1,200.00
1,016.00
853.00
712.00
512.00
Expenditure (Ex Depriciation)
Stock Adjustments
-14.00
-12.00
-15.00
-23.00
-4.00
Raw Materials Consumed
320.00
241.00
195.00
187.00
134.00
Power & Fuel Cost
112.00
104.00
97.00
71.00
37.00
Employee Cost
138.00
123.00
110.00
95.00
62.00
Operating Expenses
26.00
27.00
24.00
17.00
30.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
34.00
33.00
23.00
21.00
15.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
11.00
8.00
13.00
22.00
15.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
693.00
584.00
509.00
439.00
307.00
Operating Profit (PBDIT) excl Other Income
506.00
432.00
343.00
273.00
204.00
Other Income
44.00
33.00
35.00
23.00
31.00
Operating Profit (PBDIT)
551.00
465.00
379.00
297.00
235.00
Interest
1.00
3.00
5.00
6.00
1.00
Profit before Depriciation and Tax
550.00
462.00
374.00
291.00
234.00
Depreciation
54.00
53.00
54.00
50.00
21.00
Profit Before Taxation & Exceptional Items
495.00
409.00
320.00
241.00
213.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
494.00
412.00
322.00
237.00
213.00
Provision for Tax
122.00
104.00
81.00
62.00
44.00
Profit After Tax
372.00
304.00
238.00
178.00
168.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,404.00
1,168.00
981.00
877.00
560.00
Profit Available for appropriations
1,776.00
1,476.00
1,221.00
1,052.00
729.00
Appropriations
1,776.00
1,476.00
1,221.00
1,052.00
729.00
Equity Dividend (%)
875.00%
875.00%
683.00%
51.20%
392.50%
Earnings Per Share
35.52
29.45
22.95
16.72
177.82
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 18.01% vs 19.20% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 17.27% vs 25.65% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -67.28% vs -38.59% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 22.39% vs 27.97% in Mar 2024
Compare Profit and Loss Results of Concord Biotech
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,200.00
4,429.00
-3,229.00
-72.91%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,200.00
4,429.00
-3,229.00
-72.91%
Expenditure (Ex Depriciation)
Stock Adjustments
-14.00
-12.00
-2.00
-16.67%
Raw Materials Consumed
320.00
702.00
-382.00
-54.42%
Power & Fuel Cost
112.00
93.00
19.00
20.43%
Employee Cost
138.00
594.00
-456.00
-76.77%
Operating Expenses
26.00
210.00
-184.00
-87.62%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
34.00
136.00
-102.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
89.00
-78.00
-87.64%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
693.00
2,233.00
-1,540.00
-68.97%
Operating Profit (PBDIT) excl Other Income
506.00
2,196.00
-1,690.00
-76.96%
Other Income
44.00
354.00
-310.00
-87.57%
Operating Profit (PBDIT)
551.00
2,550.00
-1,999.00
-78.39%
Interest
1.00
23.00
-22.00
-95.65%
Profit before Depriciation and Tax
550.00
2,526.00
-1,976.00
-78.23%
Depreciation
54.00
235.00
-181.00
-77.02%
Profit Before Taxation & Exceptional Items
495.00
2,291.00
-1,796.00
-78.39%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
494.00
2,291.00
-1,797.00
-78.44%
Provision for Tax
122.00
408.00
-286.00
-70.10%
Profit After Tax
372.00
1,883.00
-1,511.00
-80.24%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,404.00
4,465.00
-3,061.00
-68.56%
Profit Available for appropriations
1,776.00
6,351.00
-4,575.00
-72.04%
Appropriations
1,776.00
6,351.00
-4,575.00
-72.04%
Equity Dividend (%)
875%
300%
575.00
Earnings Per Share
35.52
105.26
-69.74
-66.25%
Profit And Loss - Net Sales
Net Sales 1,200.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.01% vs 19.20% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 506.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.27% vs 25.65% in Mar 2024
Profit And Loss - Interest
Interest 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -67.28% vs -38.59% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 372.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 22.39% vs 27.97% in Mar 2024






